These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 20850305

  • 1. Inhibitory activity of four demethoxy fluorinated anthracycline analogs against five human-tumor cell lines.
    Horton D, Khare A.
    Bioorg Med Chem Lett; 2010 Nov 01; 20(21):6179-81. PubMed ID: 20850305
    [Abstract] [Full Text] [Related]

  • 2. Anthracycline glycosides of 2,6-dideoxy-2-fluoro-alpha-L-talopyranose.
    Horton D, Khare A.
    Carbohydr Res; 2006 Nov 27; 341(16):2631-40. PubMed ID: 17022957
    [Abstract] [Full Text] [Related]

  • 3. Influence of the structure of new anthracycline antibiotics on their biological properties.
    Wasowska M, Oszczapowicz I, Wietrzyk J, Opolski A, Madej J, Dzimira S, Oszczapowicz J.
    Anticancer Res; 2005 Nov 27; 25(3B):2043-8. PubMed ID: 16158943
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and antitumor activity of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl) daunomycinone derivatives modified at C-3' or C-4'.
    Takagi Y, Kobayashi N, Chang MS, Lim GJ, Tsuchiya T.
    Carbohydr Res; 1998 Feb 27; 307(3-4):217-32. PubMed ID: 9675364
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and antitumor activity of 7-O-[2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)-alpha-L-talopyranosyl]- daunomycinone and -adriamycinone.
    Nakai K, Takagi Y, Tsuchiya T.
    Carbohydr Res; 1999 Mar 31; 316(1-4):47-57. PubMed ID: 10420587
    [Abstract] [Full Text] [Related]

  • 6. Syntheses and antitumor activities of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
    Tsuchiya T, Takagi Y, Ok K, Umezawa S, Takeuchi T, Wako N, Umezawa H.
    J Antibiot (Tokyo); 1986 May 31; 39(5):731-3. PubMed ID: 3733524
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis of antitumor-active 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
    Ok K, Takagi Y, Tsuchiya T, Umezawa S, Umezawa H.
    Carbohydr Res; 1987 Nov 15; 169():69-81. PubMed ID: 3427590
    [Abstract] [Full Text] [Related]

  • 9. Formation of squaric acid amides of anthracycline antibiotics. Synthesis and cytotoxic properties.
    Tevyashova A, Sztaricskai F, Batta G, Herczegh P, Jeney A.
    Bioorg Med Chem Lett; 2004 Sep 20; 14(18):4783-9. PubMed ID: 15324908
    [Abstract] [Full Text] [Related]

  • 10. [Models of preclinical studies of anthracyclines].
    Fizames C.
    Pathol Biol (Paris); 1987 Jan 20; 35(1):41-8. PubMed ID: 3550611
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis and biological activity of 7-O-(4-O-acetyl-3-iodo-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl) daunomycinone and 7-O-(3-chloro-2,3,6-trideoxy-4-O-propanoyl-alpha-L-lyxo- hexopyranosyl)daunomycinone.
    Aligiannis N, Pouli N, Marakos P, Mitaku S, Skaltsounis AL, Leonce S, Pierre A, Atassi G.
    Chem Pharm Bull (Tokyo); 2000 Jan 20; 48(1):150-3. PubMed ID: 10705494
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxic activity of some glycoconjugates including saponins and anthracyclines.
    Ekholm FS, Berényi Á, Lagerquist L, Saloranta T, Zupkó I, Schneider G, Wölfling J, Leino R.
    Carbohydr Res; 2012 Jul 15; 356():295-8. PubMed ID: 22520504
    [Abstract] [Full Text] [Related]

  • 13. [New anthracycline antibiotics and derivatives].
    Tatsuta K.
    Gan To Kagaku Ryoho; 1984 Dec 15; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological and toxicological aspects of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a novel antineoplastic agent.
    Geroni C, Ripamonti M, Arrigoni C, Fiorentini F, Capolongo L, Moneta D, Marchini S, Della Torre P, Albanese C, Lamparelli MG, Ciomei M, Rossi R, Caruso M.
    Cancer Res; 2001 Mar 01; 61(5):1983-90. PubMed ID: 11280756
    [Abstract] [Full Text] [Related]

  • 15. Synthesis of 7-O-[2,6-dideoxy-2-fluoro-4-O-(3-fluorotetrahydropyran-2-yl)- alpha-L-talopyranosyl]daunomycinone.
    Takagi Y, Sohtome H, Tsuchiya T, Umezawa S, Takeuchi T.
    J Antibiot (Tokyo); 1992 Mar 01; 45(3):355-62. PubMed ID: 1577663
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A, Liu LF, Israel M, Seshadri R, Koseki Y, Giuliani FC, Kirschenbaum S, Silber R, Potmesil M.
    Cancer Res; 1989 Nov 01; 49(21):5969-78. PubMed ID: 2551497
    [Abstract] [Full Text] [Related]

  • 18. Synthesis of daunorubicin analogues containing truncated aromatic cores and unnatural monosaccharide residues.
    Fan E, Shi W, Lowary TL.
    J Org Chem; 2007 Apr 13; 72(8):2917-28. PubMed ID: 17373847
    [Abstract] [Full Text] [Related]

  • 19. Structure-based design of a new bisintercalating anthracycline antibiotic.
    Chaires JB, Leng F, Przewloka T, Fokt I, Ling YH, Perez-Soler R, Priebe W.
    J Med Chem; 1997 Jan 31; 40(3):261-6. PubMed ID: 9022792
    [Abstract] [Full Text] [Related]

  • 20. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y, Nakagawa K, Fujiwara Y, Sasaki Y, Minato K, Bungo M, Niimi S, Horichi N, Fukuda M, Saijo N.
    Cancer Res; 1989 Aug 01; 49(15):4098-102. PubMed ID: 2472873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.